Pfizer and BioNTech, at the “request from US FDA” initiate rolling submission for Emergency Use Authorization (EUA) of their COVID-19 vaccine in children under 5 years old (6 Months to 4 years of age). The request is for “the first two doses of a planned three-dose” vaccine regimen.
The clinical trials for Pfizer, in 1300 children, failed in this age group, prompting a booster shot in the trials.
In trials with older children, participants such as Maddy Garay were severely injured, yet Pfizer reported her injury as a stomach ache. The vaccine was approved regardless! [3]
An urgent “call to action” went out to stop this under 5 yr EUA, a prelude to a forever “liability shield“. [2]
On February 11, 2022, the FDA announced it would “delay it’s decision” for EUA, and Pfizer announced it’s intent to “extend the rolling submission”, yet it was reported they “withdrew” their application. [1]